-3.3 | | SND1 | 'lurbinectedin; 10 nanomolar' vs 'none' | compound | Whole transcriptome profiling by microarray of monocytes stimulated with LPS and treated with trabectedin, lurbinectedin or doxorubicin |
-2.9 | | SND1 | 'trabectedin; 10 nanomolar' vs 'none' | compound | Whole transcriptome profiling by microarray of monocytes stimulated with LPS and treated with trabectedin, lurbinectedin or doxorubicin |
2.2 | | SND1 | 'CD3/CD28 beads' vs 'none' in 'none' | stimulus, xenograft | RNA-Seq of T cells sorted from human PBMCs, or from T cells stimulated with CD3/CD28 beads for 4 days, or from the spleen of NSG or NSG-HLA-A2/HHD mice, 7 days after transplantation with human PBMCs |
-2.2 | | SND1 | 'cisplatin' at '24 hour' vs 'none' at '0 hour' | compound, time | Transcription profiling by array of human U87 cells treated with cytotoxic anticancer drug cisplatin or a ruthenium-based compound for 6 or 24 hours compared to untreated controls |
-1.9 | | SND1 | 'P-bodies (cytosolic RNP granules)' vs 'pre-sorted fraction' | fraction | RNA-Seq of purified P-bodies from HEK293 cells |
1.5 | | SND1 | 'injected in NSG mouse' vs 'none' in 'none' | stimulus, xenograft | RNA-Seq of T cells sorted from human PBMCs, or from T cells stimulated with CD3/CD28 beads for 4 days, or from the spleen of NSG or NSG-HLA-A2/HHD mice, 7 days after transplantation with human PBMCs |
1.5 | | SND1 | 'injected in NSG-HLA-A2/HHD mouse' vs 'none' in 'none' | stimulus, xenograft | RNA-Seq of T cells sorted from human PBMCs, or from T cells stimulated with CD3/CD28 beads for 4 days, or from the spleen of NSG or NSG-HLA-A2/HHD mice, 7 days after transplantation with human PBMCs |
1.5 | | SND1 | 'pancreatic ductal adenocarcinoma, neoplasm' vs 'normal; normal tissue' in 'pancreas' | disease, organism part | Transcription profiling by array of normal pancreas, primary pancreatic ductal adenocarcinoma (PDAC), normal liver, and pancreatic liver metastases using the Affymetrix HG-U133A array |
-1.5 | | SND1 | 'pancreatic cancer' vs 'normal' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]' | disease | Molecular analysis of precursor lesions in familial pancreatic cancer |
1.5 | | SND1 | 'astrocytoma' vs 'normal' | disease | Transcription profiling of human grade II astrocytic tumor (astrocytomas) vs grade IV tumors (glioblastoma) |
1.4 | | SND1 | 'tumor' vs 'paratumoral tissue' | clinical information | Transcriptomic characterization of Hepatocellular Carcinoma with CTNNB1 mutation |
-1.4 | | SND1 | 'Ataxia-telangiectasia' vs 'normal' | disease | Ataxia-telangiectasia cerebellar cortex expression |
-1.4 | | SND1 | "after autologous stem cell transplantation" vs "before autologous stem cell transplantation" | time | RNA-seq of human multiple myeloma patients myeloid-derived suppressor cells (M-MDSC) |
1.3 | | SND1 | 'Human gammaherpesvirus 4' at '14 day' vs 'none' at '0 day' | infect, time | Infection of naïve primary human B-lymphocytes with Epstein-Barr virus (EBV) – time course transcriptomic analysis in the pre-latent phase of viral infection |
1.3 | | SND1 | 'T-helper 1 polarising' at '1 day' vs 'no stimulus' | cell type, sampling time point, stimulus | Transcription profiling by array of human CD4+T-cells, Th1/Th2 polarized time-series and primary memory subsets |
1.2 | | SND1 | 'Human gammaherpesvirus 4' at '2 day' vs 'none' at '0 day' | infect, time | Infection of naïve primary human B-lymphocytes with Epstein-Barr virus (EBV) – time course transcriptomic analysis in the pre-latent phase of viral infection |
1.2 | | SND1 | 'Human gammaherpesvirus 4' at '3 day' vs 'none' at '0 day' | infect, time | Infection of naïve primary human B-lymphocytes with Epstein-Barr virus (EBV) – time course transcriptomic analysis in the pre-latent phase of viral infection |
1.2 | | SND1 | 'MOLT-4; acute lymphoblastic leukemia; P04' vs 'MOLT-4; acute lymphoblastic leukemia; P0' | cell line, disease, passage | Microarray analysis of xenograft models in use at the Developmental Therapeutics Program of the National Cancer Institute (DTP-NCI) |
1.2 | | SND1 | 'plasmablast' vs 'memory B cell' | cell type | Transcription profiling by array of human activated B cells, plasmablasts and plasma cells compared to memory B cells |
-1.2 | | SND1 | 'Zaire ebolavirus lacking the mucin domain of GP' vs 'mock' at '8 hour' | infect, time | Human U937 cell transcriptome response to Zaire Ebola virus wild-type in the delta-VP30 background and delta-mucin virus |
1.2 | | ENSG00000197157 | 'primary tumor' vs 'adjacent non-tumor colon' in 'colorectal cancer' | disease, sampling site | RNA-seq of colorectal cancer primary tumor and adjacent colon tissue |
-1.2 | | SND1 | 'Influenza A virus' vs 'mock' in 'PBS' | compound, infect | Profiling of human bronchial epithelial BEAS-2B infected with influenza A and treated with succinate to study the anti-influenza activity of succinate |
-1.2 | | SND1 | 'PanIN lesion' vs 'normal' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]' on 'Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]' | disease | Molecular analysis of precursor lesions in familial pancreatic cancer |
1.1 | | SND1 | 'Human gammaherpesvirus 4' at '4 day' vs 'none' at '0 day' | infect, time | Infection of naïve primary human B-lymphocytes with Epstein-Barr virus (EBV) – time course transcriptomic analysis in the pre-latent phase of viral infection |
-1.1 | | SND1 | 'tumor necrosis factor alpha' vs 'none' in 'brain microvascular endothelial cell; monoculture' | cell type, growth condition, stimulus | Reactive astrocytes transduce blood-brain barrier inflammation through a TNFα-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin |
-1.1 | | SND1 | 'CRISPR-Cas9 induced GNRH1 reporter; 27 day' vs 'wild type genotype; 20 day' | genotype, stimulus, time | RNA-Seq of GNRH1 neurons differentiated from human pluripotent stem cells |
1.1 | | SND1 | 'medulloblastoma, large-cell' vs 'normal' | disease | Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes |
1.1 | | SND1 | 'T-helper 2 polarising' at '1 day' vs 'no stimulus' | cell type, sampling time point, stimulus | Transcription profiling by array of human CD4+T-cells, Th1/Th2 polarized time-series and primary memory subsets |
1.1 | | SND1 | 'psoriasis' vs 'normal' in 'Ovation RNA Amplification V2 kit' | disease, protocol | Dominant Th1 and Minimal Th17 Skewing in Discoid Lupus Revealed by Transcriptomic Comparison with Psoriasis |
1.1 | | SND1 | '24 hours with hMSC Adipogenic Differentiation Bullet Kit' vs 'none' in 'monosome' | fraction, protocol | RNA-seq of total RNA from human adipose tissue stem cells induced to adipogenesis and osteogenesis for 24 hours |
-1 | | SND1 | 'doxycycline; 0.5 microgram per milliliter; Day 4 post Neurogenin induction' vs 'control' | compound, treatment | Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) |
1 | | SND1 | 'JQ1 (1 micromolar) and THZ1 (35 nanomolar)' vs 'none' | compound | RNA-seq of IMR-5/75 neuroblastoma cell line treated with JQ1, THZ1 or combination against untreated controls |
1 | | SND1 | 'Human gammaherpesvirus 4' at '5 day' vs 'none' at '0 day' | infect, time | Infection of naïve primary human B-lymphocytes with Epstein-Barr virus (EBV) – time course transcriptomic analysis in the pre-latent phase of viral infection |
-1 | | SND1 | 'Digoxin; 400 nanomolar' vs 'DMSO' | compound | Expression profiling of Jurkat cells infected with HIV-1 and treated with digoxin or DMSO |
1 | | SND1 | 'AQM' vs 'normal' on 'Affymetrix HG-U133A' | disease | Transcription profiling by array of 12 human muscle diseases |
1 | | SND1 | 'activated B cell' vs 'memory B cell' | cell type | Transcription profiling by array of human activated B cells, plasmablasts and plasma cells compared to memory B cells |
1 | | SND1 | 'plasma cell' vs 'memory B cell' | cell type | Transcription profiling by array of human activated B cells, plasmablasts and plasma cells compared to memory B cells |
1 | | SND1 | 'Human gammaherpesvirus 4' at '8 day' vs 'none' at '0 day' | infect, time | Infection of naïve primary human B-lymphocytes with Epstein-Barr virus (EBV) – time course transcriptomic analysis in the pre-latent phase of viral infection |
-1 | | SND1 | 'differentiated; hAKPC-P' vs 'undifferentiated; hAKPC-P' | cell type, phenotype | Differentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes |
-1 | | SND1 | 'lymphangiogenic and very metastatic' vs 'parental pool' | phenotype | Expression data from melanoma subpopulations |
1 | | SND1 | 'group 3 medulloblastoma' vs 'normal' | disease | Gene expression profile of pediatric and adult brain tumor types and normal brain |
1 | | SND1 | 'lung cancer' vs 'normal' in 'lung; Formalin-fixed paraffin-embedded tissue' | disease, organism part, protocol | Transcription profiling by array of formalin-fixed paraffin-embedded or fresh frozen human tumor samples |
-1 | | SND1 | 'type I diabetes mellitus' vs 'normal' | disease staging | Transcription profiling human whole blood from children with pre-type1diabetes |
-1 | | SND1 | 'diabetes mellitus' vs 'normal' | disease | An integrative analysis of skeletal muscle insulin resistance |
1 | | SND1 | 'TGFbeta3' vs 'control' at '3 day' | growth condition, time | Transcription profiling by array of human bone marrow mesenchymal stem cells after treatment with BMP2 or TGFbeta-3 |
1 | | SND1 | 'PKA RI-alpha over expression' vs 'wild type' | genotype | Transcription profiling by array of human ovarian cancer cells over-expressing PKA regulatory subunits |
1 | | SND1 | 'liver tumor' vs 'adjacent non-tumor tissue' | clinical information | Transcriptome sequencing of human hepatocellular carcinoma |
0.6 | | ENSG00000197157 | 'intravascular lymphoma' vs 'diffuse large B-cell lymphoma' | disease | 113 DLBCL SWATH maps by PCT-SWATH |
-0.5 | | ENSG00000197157 | 'tumor' vs 'normal tissue' in 'frozen specimen' | sampling site, specimen with known storage state | Comparison of FFPE and fresh frozen prostate tissues using PCT SWATH |